This document discusses criteria for diagnosing hyperglycemia during pregnancy based on a study called HAPO and recommendations from IADPSG. Some key points:
- HAPO found associations between increasing maternal glucose levels (fasting, 1 hour, and 2 hour plasma glucose) and adverse pregnancy outcomes like large-for-gestational-age babies, without obvious thresholds.
- Based on HAPO data, IADPSG recommended diagnosing gestational diabetes with only one abnormal glucose value on a 75g oral glucose tolerance test: fasting ≥92 mg/dL, 1 hour ≥180 mg/dL, or 2 hour ≥153 mg/dL.
- Using the IADPSG criteria
Invited Lecture delivered by Dr Sujoy Dasgupta in a CME, sponsored by Serum Institute of India Pvt Ltd in the Convocation Ceremony of Interns at Sagor Dutta Medical College
ESHRE Guideline on Recurrent Pregnancy Loss (RPL)Sujoy Dasgupta
Dr Sujoy Dasgupta invited to deliver a lecture on "RPL- ESHRE Guideline" in the Annual Conference of RCOG (Royal College of Obstetricians and Gynaecologists) IRC (International Representative Committee) India East held on 20-21 May, 2023
Invited Lecture delivered by Dr Sujoy Dasgupta in a CME, sponsored by Serum Institute of India Pvt Ltd in the Convocation Ceremony of Interns at Sagor Dutta Medical College
ESHRE Guideline on Recurrent Pregnancy Loss (RPL)Sujoy Dasgupta
Dr Sujoy Dasgupta invited to deliver a lecture on "RPL- ESHRE Guideline" in the Annual Conference of RCOG (Royal College of Obstetricians and Gynaecologists) IRC (International Representative Committee) India East held on 20-21 May, 2023
Management of Endometrioma- Current UpdateSujoy Dasgupta
Invited Lecture by Dr Sujoy Dasgupta in the Webinar on "Update on Endometriosis" organized by AICC RCOG (All India Coordinating Committee of Royal College of Obstetricians and Gynaecologists) East Zone, held in December, 2021
This talk was delivered for postgraduates and faculty of Dr. TMA Pai Hospital, Udupi on 07 March, 2017. This talk covered pathophysiology, screening, diagnosis, complications and management of diabetes mellitus in pregnancy.
In gynecologic cancers, fertility preservation strategies include fertility-sparing surgical approaches and assisted reproductive technologies (ART). Fertility preservation can be considered in women with early stage I epithelial ovarian cancer and most borderline tumors, stages I–III
Embryo implantation in the region of a previous caesarean section scar is a rare but potentially catastrophic complication of a previous cesarean birth.
Management of Endometrioma- Current UpdateSujoy Dasgupta
Invited Lecture by Dr Sujoy Dasgupta in the Webinar on "Update on Endometriosis" organized by AICC RCOG (All India Coordinating Committee of Royal College of Obstetricians and Gynaecologists) East Zone, held in December, 2021
This talk was delivered for postgraduates and faculty of Dr. TMA Pai Hospital, Udupi on 07 March, 2017. This talk covered pathophysiology, screening, diagnosis, complications and management of diabetes mellitus in pregnancy.
In gynecologic cancers, fertility preservation strategies include fertility-sparing surgical approaches and assisted reproductive technologies (ART). Fertility preservation can be considered in women with early stage I epithelial ovarian cancer and most borderline tumors, stages I–III
Embryo implantation in the region of a previous caesarean section scar is a rare but potentially catastrophic complication of a previous cesarean birth.
Presentation at the annual scientific conference of the DOST-National Research Council of the Philippines, 12 Mar 2024. Philippine International Convention Center, Manila.
Artificial Intelligence: Ethical Issues in Residency TrainingIris Thiele Isip-Tan
Symposium presentation at the annual convention of the Philippine Academy of Family Physicians, 8 March 2024. Philippine International Convention Center.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAkankshaAshtankar
MIP 201T & MPH 202T
ADVANCED BIOPHARMACEUTICS & PHARMACOKINETICS : UNIT 5
APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS By - AKANKSHA ASHTANKAR
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
When Hyperglycemia Strikes Pregnancy: Criteria for Diagnosis
1. WHEN HYPERGLYCEMIA
STRIKES PREGNANCY:
CRITERIA FOR DIAGNOSIS
Iris Thiele Isip Tan MD, MSc, FPCP, FPSEM
Clinical Associate Professor, UP College of Medicine
Section of Endocrinology, Diabetes & Metabolism
Department of Medicine, Philippine General Hospital
Tuesday, November 8, 11
2. UNITE for Diabetes
CPG on screening &
International diagnosis of GDM
Association of Diabetes
Hyperglycemia in Pregnancy Study
Adverse Pregnancy Groups (IADPSG)
Outcomes (HAPO)
Tuesday, November 8, 11
5. OR for adverse pregnancy outcomes
1 level SD
increase
FPG 6.9 mg/dL (0.4 mmol/L)
1 h PG 30.9 mg/dL (1.7 mmol/L)
2 h PG 23.5 mg/dL (1.3 mmol/L)
HAPO NEJM 2008; 358:1991-2002
Tuesday, November 8, 11
6. HAPO NEJM 2008; 358:1991-2002
BW>90th %ile
1h PG
1.46
(95%CI 1.39,1.53)
Fasting
1.38
OR for (95%CI 1.32,1.44)
2h PG
adverse 1.38
pregnancy (95%CI 1.32,1.44)
outcomes
http://www.flickr.com/photos/mikewade/3267336862/
Tuesday, November 8, 11
7. HAPO NEJM 2008; 358:1991-2002
Cord blood serum
C-peptide >90 %ile
1h PG
1.46
(95%CI 1.38,1.54)
Fasting
1.55
OR for (95%CI 1.47,1.64)
2h PG
adverse 1.37
pregnancy (95%CI 1.30,1.44)
outcomes
http://www.flickr.com/photos/clairity/1385780317/
Tuesday, November 8, 11
8. HAPO NEJM 2008; 358:1991-2002
Primary CS
1h PG
1.10
(95%CI 1.06,1.15)
Fasting
1.11
OR for (95%CI 1.06,1.15)
2h PG
adverse 1.08
pregnancy (95%CI 1.03,1.12)
outcomes
http://www.flickr.com/photos/j2dread/4501366303/
Tuesday, November 8, 11
9. HAPO NEJM 2008; 358:1991-2002
Neonatal hypoglycemia
1h PG
1.13
(95%CI 1.03,1.26)
Fasting
1.08
OR for (95%CI 0.98,1.19)
2h PG
adverse 1.10
pregnancy (95%CI 1.00,1.12)
outcomes
http://www.flickr.com/photos/tessawatson/379265818/
Tuesday, November 8, 11
10. No obvious
threshold
at which risks increased
HAPO NEJM 2008; 358:1991-2002
Tuesday, November 8, 11
11. No obvious
threshold FPG mg/dL
at which risks increased Category
1 <75
2 75-79
3 80-84
4 85-89
5 90-94
6 95-99
7 >100
HAPO NEJM 2008; 358:1991-2002
Tuesday, November 8, 11
12. No obvious
threshold 1h PG mg/dL
at which risks increased Category
1 <105
2 106-132
3 133-155
4 156-171
5 172-193
6 194-211
7 >212
HAPO NEJM 2008; 358:1991-2002
Tuesday, November 8, 11
13. No obvious
threshold 2h PG mg/dL
at which risks increased Category
1 <90
2 91-108
3 109-125
4 126-139
5 140-157
6 158-177
7 >178
HAPO NEJM 2008; 358:1991-2002
Tuesday, November 8, 11
14. Macrosomia
C-section
Hypoglycemia
C-peptide
HAPO NEJM 2008; 358:1991-2002
Tuesday, November 8, 11
15. “... the relationship between
maternal glucose levels and fetal
growth and outcome appear to be
a basic biologic phenomenon, and
not a clearly demarcated
disease state ...”
Coustan et al. AJOG 2010; 202(6):654.e1-654.e6
Tuesday, November 8, 11
17. IADPSG
encourage and facilitate
research and advance
education
facilitate an international
approach to enhancing the
quality of care for women
with diabetes in pregnancy
http://www.sxc.hu/photo/358002
Coustan et al. AJOG 2010; 202(6):654.e1-654.e6
Tuesday, November 8, 11
18. IADPSG
workshop/conference
June 2008
(220 delegates
approx 40 countries)
consensus development
session (50 delegates)
Coustan et al. AJOG 2010; 202(6):654.e1-654.e6
Tuesday, November 8, 11
19. OR for increased neonatal body
fat, LGA and cord serum C-peptide
Mean
glucose as
reference
Positive Predictive Value
% for >90th %ile
OR Subjects >
Birth
Threshold C-peptide % Body fat
weight
1.75 16.1 16.2 17.5 16.6
2.0 8.8 17.6 19.7 18.8
Coustan et al. AJOG 2010; 202(6):654.e1-654.e6
Tuesday, November 8, 11
20. IADPSG recommendation for diagnosis of GDM
FBS 92 mg/dL
Diagnosis requires only one
1h 180 mg/dL threshold value exceeded
2h 153 mg/dL
Coustan et al. AJOG 2010; 202(6):654.e1-654.e6
Tuesday, November 8, 11
21. IADPSG recommendation for diagnosis of GDM
FBS 92 mg/dL
Diagnosis requires only one
1h 180 mg/dL threshold value exceeded
2h 153 mg/dL
ADA
FBS 95 mg/dL
1h 180 mg/dL
2h 155 mg/dL
Coustan et al. AJOG 2010; 202(6):654.e1-654.e6
Tuesday, November 8, 11
22. First prenatal visit
Measure FPG, A1c or random
plasma glucose in all or only in high-risk
Overt
Diabetes in
Gestational Order a 75-g
Pregnancy
Diabetes OGTT at 24-28
FPG > 7 mmol/L wks AOG
A1c > 6.5% FPG
Random PG > 5.1-6.9 mmol/L FPG
11.1 mmol/L (92-125 mg/dL) <5.1 mmol/L
IADPSG Consensus Panel. Diabetes Care Mar 2010;33(3):676-82
Tuesday, November 8, 11
23. IADPSG recommendation for diagnosis of GDM
FBS 92 mg/dL
24-28 wks AOG
1h 180 mg/dL Diagnosis requires only one
threshold value exceeded
2h 153 mg/dL
Overt diabetes
FPG >7.0 mmol/L (126 mg/dL)
Coustan et al. AJOG 2010; 202(6):654.e1-654.e6
Tuesday, November 8, 11
24. Use of IADPSG criteria
http://www.flickr.com/photos/kkoshy/4334413228/
More women will be diagnosed with GDM
17.8% of pregnant women
Ryan EA. Diabetologia 2011; 54:480-6
Tuesday, November 8, 11
25. Using HAPO data
+ 1,702 women with GDM
of 23,316 pregnancies
Nurses, dietitians &
physicians
Glucose monitoring
Therapy of diabetes
Ryan EA. Diabetologia 2011; 54:480-6
Tuesday, November 8, 11
26. Diagnosis of GDM identifies
women at risk of type 2 diabetes
IADPSG criteria may
overestimate
high rates of
diabetes in women
with GDM history
Tuesday, November 8, 11
27. X 140 cases of LGA
X 21 cases of shoulder dystocia
X 16 cases of birth injury
Ryan EA. Diabetologia 2011; 54:480-6 http://www.sxc.hu/photo/249796
Tuesday, November 8, 11
28. X 140 cases of LGA
X 21 cases of shoulder dystocia
X 16 cases of birth injury
Modest
outcomes?
Ryan EA. Diabetologia 2011; 54:480-6 http://www.sxc.hu/photo/249796
Tuesday, November 8, 11
29. 78% of LGA born to
FBS undiagnosed women
92 mg/dL
1h
180 mg/dL
2h
X
153 mg/dL
BW>90th %ile
Ryan EA. Diabetologia 2011; 54:480-6
Tuesday, November 8, 11
30. report used an adjustment (Model 1) for many of the
expected confounders (age, alcohol, smoking, sex etc.), and
Greater impact of maternal BMI on
also a model (Model 2) that adjusted for fasting plasma
OR for LGA than maternal glucose
except highest glucose category
a b
8,000
5
● 6,000 Model 1
BMI
Women (n)
4
▲ 4,000 Model 2
BMI
OR
3
2 ◆ Maternal FG
2,000
1
0 0
1 2 3 4 5 6 7 1 2 3
Glucose category
Glucos
<22.6 22.6− 28.5− 33.0− 37.5− 42.0
28.4 32.9 37.4 41.9
BMI category (Kg/m2)
Fig. 1 a Relationship of the OR for an infant of birthweight >90th
Model 1: Adjusted for age, alcohol, smoking, sex, etc. HAPO
Model 2: Adjusted for mean FG and MAP 2
percentile vs the BMI in categories (reference group BMI <22.6 kg/m
Ryan EA. Diabetologia 2011; 54:480-6
[4]) or maternal fasting glucose in categories from HAPO (diamonds;
Tuesday, November 8, 11
31. icular glucose category; the category incorporating the mean glucose level. This is
r the glucose range. also true for the 1 and 2 h post-load challenge (ESM
roup examined the role Fig. 3). It is also noteworthy that at category 5 (equivalent
Majority of women IADPSG cut-off criteria, accepting that some cases in
mary outcomes [4]. This to the had Most cases of LGA occur
l 1) for many oflevels category 5 will lie abovenormal maternal
glucose the < Cat. 3 in these cut-offs within category 5)
smoking, sex etc.), and women below these cut-offs who had LGA represented
(mean glucose level) glycemia
sted for fasting plasma 78% of all women giving birth to LGA.
b c
8,000 700
600
6,000 500
Women (n)
Women (n)
400
4,000
300
2,000 200
100
0 0
1 2 3 4 5 6 7 1 2 3 4 5 6 7
Glucose category Glucose category
☐ Participants
infant of birthweight >90th (see text for details). The relationship for maternal fasting glucose
■ Participants with LGA infants
nce group BMI <22.6 kg/m2
ies from HAPO (diamonds;
categories is also shown (black diamonds). b Number of participants
in each category of glucose in HAPO (white bars), with number of
HAPO
lucose [2]). a The BMI c Number of participants in
mothers with LGA infants (black bars).Ryan EA. Diabetologia 2011; 54:480-6
cles) or model 2 (triangles) each category of glucose who had LGA infants
Tuesday, November 8, 11
32. Proposed IADPSG diagnostic criteria are based
on LGA, cord-C peptide and fetal adiposity.
Treatment
reduces
perinatal
ACHOIS morbidity
Landon et al
Crowther et al.
NEJM 2009;
NEJM 2005;
361:1339-48.
352:2477-86.
Tuesday, November 8, 11
33. ACHOIS
Crowther et al.
NEJM 2005; M
352:2477-86.
O Randomized
controlled
I Serious trial
perinatal
P Intervention complications
(n=490)
death
diet CBG insulin shoulder dystocia
vs bone fracture
nerve palsy
routine care
(n=510)
GDM
24-28 wks AOG
Crowther CA et al. Effect of Treatment of Gestational Diabetes
Mellitus on Pregnancy Outcomes. NEJM 2005; 352:2477-86.
Tuesday, November 8, 11
34. Any serious perinatal complication
ACHOIS Adj RR 0.33 (95% CI 0.14-0.75), p=0.01
Crowther et al.
NEJM 2005; M
352:2477-86.
O Randomized
controlled
I Serious trial
perinatal
P Intervention complications
(n=490)
death
diet CBG insulin shoulder dystocia
vs bone fracture
nerve palsy
routine care
(n=510)
GDM
24-28 wks AOG
Crowther CA et al. Effect of Treatment of Gestational Diabetes
Mellitus on Pregnancy Outcomes. NEJM 2005; 352:2477-86.
Tuesday, November 8, 11
35. Landon et al
NEJM 2009; M
361:1339-48.
O Randomized
Composite of controlled
I stillbirth/ trial
perinatal
P Intervention death and
(n=485)
neonatal
diet CBG insulin
complications
vs hyperbilirubinemia
routine care hypoglycemia
(n=473) hyperinsulinemia
birth trauma
“mild” GDM
24-31 wks AOG
Landon MB et al. A multicenter, randomized trial of treatment
for mild gestational diabetes. NEJM 2009; 361:1339-48.
Tuesday, November 8, 11
36. Composite endpoint
RR 0.87 (95% CI 0.72-1.07), p=0.14
Landon et al
NEJM 2009; M
361:1339-48.
O Randomized
Composite of controlled
I stillbirth/ trial
perinatal
P Intervention death and
(n=485)
neonatal
diet CBG insulin
complications
vs hyperbilirubinemia
routine care hypoglycemia
(n=473) hyperinsulinemia
birth trauma
“mild” GDM
24-31 wks AOG
Landon MB et al. A multicenter, randomized trial of treatment
for mild gestational diabetes. NEJM 2009; 361:1339-48.
Tuesday, November 8, 11
37. Composite endpoint
RR 0.87 (95% CI 0.72-1.07), p=0.14
Landon et al
NEJM 2009; M
361:1339-48.
O Randomized
controlled
I trial
P Intervention
(n=485)
diet CBG insulin
vs
routine care
(n=473)
“mild” GDM
24-31 wks AOG
Landon MB et al. A multicenter, randomized trial of treatment
for mild gestational diabetes. NEJM 2009; 361:1339-48.
Tuesday, November 8, 11
38. Composite endpoint
RR 0.87 (95% CI 0.72-1.07), p=0.14
Landon et al
NEJM 2009; M
361:1339-48.
O Randomized
LGA infants controlled
I RR 0.49 trial
P Intervention (95%CI 0.32-0.76)
p<0.001
(n=485)
diet CBG insulin BW >4000 g
vs RR 0.41
routine care (95%CI 0.26-0.66)
(n=473) p<0.001
“mild” GDM
24-31 wks AOG
Landon MB et al. A multicenter, randomized trial of treatment
for mild gestational diabetes. NEJM 2009; 361:1339-48.
Tuesday, November 8, 11
39. OGTT is poorly reproducible
Diagnosis based on a single
test, on a single abnormal value
Ryan EA. Diabetologia 2011; 54:480-6 http://www.flickr.com/photos/craigoneal/4084388198/
Tuesday, November 8, 11
40. HAPO data collected
at 24-28 wks AOG
Fasting glucose
5.1 mmol/L
at 7 wks AOG
= GDM
Ryan EA. Diabetologia 2011; 54:480-6
Tuesday, November 8, 11
41. IADPSG
ACOG recommends
against IADPSG consensus
1. All pregnant women should be
screened for GDM by patient
history, clinical risk factors or a
50-g, 1-hour loading test to
determine blood glucose levels.
ACOG Committee on Obstetric Practice. Screening & Diagnosis of
http://www.sxc.hu/photo/358002 Gestational Diabetes Mellitus. Obstetrics & Gynecology 2011; 118(3):751-3
Tuesday, November 8, 11
42. IADPSG
ACOG recommends
against IADPSG consensus
2. The diagnosis of GDM can be
made based on the result of the
100-g, 3h OGTT.
Carpenter & Coustan or NDDG criteria
ACOG Committee on Obstetric Practice. Screening & Diagnosis of
http://www.sxc.hu/photo/358002 Gestational Diabetes Mellitus. Obstetrics & Gynecology 2011; 118(3):751-3
Tuesday, November 8, 11
43. ACOG recommends
IADPSG against IADPSG
consensus
3. Diagnosis of GDM based on
the 1-step screening and
diagnosis test outlined in the
IADPSG guidelines is not
recommended at this time
because there is no evidence that
diagnosis using these criteria leads to
clinically significant improvement in
maternal or newborn outcomes, and it
would lead to a significant increase in
healthcare costs.
ACOG Committee on Obstetric Practice. Screening & Diagnosis of
http://www.sxc.hu/photo/358002 Gestational Diabetes Mellitus. Obstetrics & Gynecology 2011; 118(3):751-3
Tuesday, November 8, 11
44. UNITE for Diabetes CPG
on screening &
diagnosis of GDM
Tuesday, November 8, 11
45. 6.1 Should universal screening for diabetes
be done among pregnant women?
Recommendation:
All pregnant women should be screened for
gestational diabetes (Level 2, Grade B).
Tuesday, November 8, 11
46. 6.2 For pregnant women, when should
screening be done?
Recommendations:
1. All pregnant women should be evaluated at the
first prenatal visit for risk factors for diabetes
(Level 4, Grade C).
Tuesday, November 8, 11
47. Risk Factors for
Gestational Diabetes
Prior history of GDM (OR 23.6 [95%CI 11.6, 48.0])3
Glucosuria (OR 9.04 [95%CI 2.6, 63.7]2; PPV 50% 4)
Family history of diabetes (OR 7.1 [95%CI 5.6, 8.9]1; OR 2.74
[95%CI 1.47, 5.11]3)
First-degree relative with type 2 diabetes (PPV 6.7%)4
First-degree relative with type 1 diabetes (PPV 15%)4
Prior macrosomic baby (OR 5.59 [95%CI 2.68, 11.7])3
Age >25 years old (OR 1.9 [95%CI 1.3, 2.7]1; OR 3.37 [95%CI
1.45, 7.85]3)
1 Davey RX, Hamblin PS. Selective versus universal screening for gestational diabetes mellitus:
an evaluation of predictive risk factors. Medical Journal of Australia 2001;174(3):118–21.
! ! 2 Schytte T, Jorgensen LG, Brandslund I, et al. The clinical impact of screening for gestational
diabetes. Clinical Chemistry and Laboratory Medicine 2004;42(9):1036–42.
3 Ostlund I, Hanson U. Occurrence of gestational diabetes mellitus and the value of different screening indicators
for the oral glucose tolerance test. Acta Obstetricia et Gynecologica Scandinavica 2003;82(2):103–8.
4 Griffin ME, Coffey M, Johnson H, et al. Universal vs. risk factor-based screening for gestational diabetes
mellitus: detection rates, gestation at diagnosis and outcome. Diabetic Medicine 2000;17(1):26–32.
Tuesday, November 8, 11
48. Risk Factors for
Gestational Diabetes
Diagnosis of polycystic ovary syndrome
(OR 2.89 [95%CI 1.68, 4.98])5
Overweight or obese before pregnancy
(BMI >27 kg/m2 OR 2.3 [95%CI 1.6, 3.3]1; BMI>30 kg/m2
OR 2.65 [95%CI 1.36, 5.14]3
Macrosomia in current pregnancy (PPV 40% 4)
Polyhydramnios in current pregancy (PPV 40% 4)
Intake of drugs affecting carbohydrate metabolism
1 Davey RX, Hamblin PS. Selective versus universal screening for gestational diabetes mellitus:
an evaluation of predictive risk factors. Medical Journal of Australia 2001;174(3):118–21.
3 Ostlund I, Hanson U. Occurrence of gestational diabetes mellitus and the value of different screening indicators
for the oral glucose tolerance test. Acta Obstetricia et Gynecologica Scandinavica 2003;82(2):103–8.
4 Griffin ME, Coffey M, Johnson H, et al. Universal vs. risk factor-based screening for gestational diabetes
mellitus: detection rates, gestation at diagnosis and outcome. Diabetic Medicine 2000;17(1):26–32.
5 Toulis KA, Goulis DG, Kolibiankis EM, Venetis CA, et al. Risk of gestational diabetes mellitus in women with
polycystic ovary syndrome: a systematic review and a meta-analysis. Fertil Steril 2009;92(2):667–77.
Tuesday, November 8, 11
49. 6.2 For pregnant women, when should
screening be done?
Recommendations:
2. High-risk women should be tested at the
soonest possible time (Level 3, Grade B).
Tuesday, November 8, 11
50. 6.2 For pregnant women, when should
screening be done?
Recommendations:
3. Routine testing for gestational diabetes is
recommended at 24-28 weeks age of gestation
for women with no risk factors (Level 3, Grade B).
Tuesday, November 8, 11
51. 6.2 For pregnant women, when should
screening be done?
Recommendations:
4. Testing for gestational diabetes should still be
carried out in women at risk, even beyond 24 to
28 weeks age of gestation (Level 3, Grade C).
Tuesday, November 8, 11
52. 6.3 Which tests should be used to screen pregnant
women for gestational diabetes?
Recommendation:
An oral glucose tolerance test (OGTT), preferably
the 75-g OGTT, should be used to screen for
gestational diabetes (Level 3, Grade B).
Tuesday, November 8, 11
53. 6.4 What criteria will be used to interpret
the 75-g OGTT?
Recommendation:
The criteria put forth by the International
Association of Diabetes & Pregnancy Study Groups
(IADPSG) will be used to interpret the 75-g OGTT
(Level 3, Grade B).
International Association of Diabetes and Pregnancy Study Groups Consensus Panel. IADPSG Recommendations on
the Diagnosis and Classification of Hyperglycemia in Pregnancy. Diabetes Care 2010; 33(3):676-82.
Tuesday, November 8, 11
54. UNITE for Diabetes
CPG on screening &
International
diagnosis of GDM
Association of Diabetes
in Pregnancy Study
Hyperglycemia
Groups (IADPSG)
Adverse Pregnancy
Outcomes (HAPO)
Tuesday, November 8, 11
55. Thank You!
http://www.endocrine-witch.net
You are all invited to the
19th UPCM Grand Scientific Symposium
Training the Clinical Eye:
Making the Essential Visible
Hyatt Hotel Manila
Jan 27-28, 2012
19thgss@gmail.com
Tuesday, November 8, 11